Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Bruno Emond"'
Autor:
Jessica A. Walsh, Iris Lin, Ruizhi Zhao, Natalie J. Shiff, Laura Morrison, Bruno Emond, Louise H. Yu, Samuel Schwartzbein, Patrick Lefebvre, Dominic Pilon, Soumya D. Chakravarty, Philip Mease
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 3, Pp 487-499 (2024)
Abstract Background Treatment persistence among patients with psoriatic arthritis (PsA) is essential for achieving optimal treatment outcomes. Guselkumab, a fully human interleukin-23p19-subunit inhibitor, was approved by the United States (US) Food
Externí odkaz:
https://doaj.org/article/5984faa752c244f89c78d0606e965338
Autor:
Brandon S. Sheffield, Kiefer Eaton, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Laura Morrison, Andrea L. Stevens, Emmanuel M. Ewara, Parneet Cheema
Publikováno v:
Current Oncology, Vol 30, Iss 2, Pp 2348-2365 (2023)
This study assessed the total costs of testing, including the estimated costs of delaying care, associated with next-generation sequencing (NGS) versus single-gene testing strategies among patients with newly diagnosed metastatic non-small cell lung
Externí odkaz:
https://doaj.org/article/e90a8fde73364e8eb8aada23d879b009
Autor:
Mazyar Shadman, Bhavini Srivastava, Sima Patel, Chadi Saifan, Monika Salkar, Bruno Emond, Priyanka Gogna, Ameur Manceur, Marie-Helene Lafeuille, Deborah Stephens
Publikováno v:
HemaSphere, Vol 7, p e24922b0 (2023)
Externí odkaz:
https://doaj.org/article/84610cca2a88495694bedd9f4e9c3430
Autor:
Matthew J. Pianko, Niodita Gupta-Werner, Bruno Emond, Patrick Lefebvre, Marie-Helene Lafeuille, Annelore Cortoos, Shuchita Kaila
Publikováno v:
HemaSphere, Vol 7, p e496346b (2023)
Externí odkaz:
https://doaj.org/article/edc1a82c232f4fd6b43fc08ce6ba5a0f
Autor:
Peter F. Rebeiro, Bruno Emond, Carmine Rossi, Brahim K. Bookhart, Aditi Shah, Gabrielle Caron‐Lapointe, Marie‐Hélène Lafeuille, Prina Donga
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss 6, Pp n/a-n/a (2023)
Abstract Introduction Integrase strand transfer inhibitor (INSTI)‐containing antiretroviral therapy (ART) has been associated with weight gain, though there is limited information on associations between ART‐related weight gain and cardiometaboli
Externí odkaz:
https://doaj.org/article/b09983ffb67848e29a814a9c2b9f6848
Autor:
Prina Donga, Bruno Emond, Aditi Shah, Brahim K Bookhart, David Anderson, Maude Vermette-Laforme, Carmine Rossi, Marie-Helene Lafeuille
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 1 (2022)
Aim: Compare weight changes between people living with HIV-1 (PLWH) at high risk of weight gain (females, Blacks or Hispanics) switching from an integrase strand transfer inhibitor (INSTI) to a protease inhibitor (PI) or another INSTI. Materials &
Externí odkaz:
https://doaj.org/article/b541c14e9798497fb026360a3786df8b
Autor:
Bruno Emond, Carmine Rossi, Rachel Rogers, Patrick Lefebvre, Marie-Hélène Lafeuille, Prina Donga
Publikováno v:
Journal of Health Economics and Outcomes Research (2022)
**Background:** While some studies among patients with HIV-1 suggest that antiretroviral therapy (ART) regimens containing tenofovir alafenamide (TAF) may be associated with greater weight gain than those not containing TAF, no studies have assessed
Externí odkaz:
https://doaj.org/article/b3d47311a04b418bb651e929bd8ef1b1
Autor:
David P. Hudesman, Soumya D. Chakravarty, Bruno Emond, Lorie A. Ellis, Patrick Lefebvre, Kay Sadik, Jose U. Scher
Publikováno v:
BMC Rheumatology, Vol 4, Iss 1, Pp 1-13 (2020)
Abstract Background Chronic inflammatory diseases (CIDs; ankylosing spondylitis [AS], psoriatic arthritis [PsA], psoriasis [PsO], or rheumatoid arthritis [RA]) and inflammatory bowel disease (IBD; Crohn’s disease and ulcerative colitis) are associa
Externí odkaz:
https://doaj.org/article/bcbb661d25e443bba9217df50f4dcc9c
Autor:
Menno Vergeer, Wendela L. deRanitz‐Greven, Maureen P. Neary, Raluca Ionescu‐Ittu, Bruno Emond, Mei Sheng Duh, Floor Jansen, Bernard A. Zonnenberg
Publikováno v:
Epilepsia Open, Vol 4, Iss 4, Pp 581-592 (2019)
Abstract Objective To estimate health‐related quality of life (HRQoL) in patients with tuberous sclerosis complex (TSC) and associated manifestations and to identify potential factors associated with HRQoL in this population of patients. Methods We
Externí odkaz:
https://doaj.org/article/14fdadbaa9134783972133ae0b26ebf0
Autor:
Charmi Patel, Bruno Emond, Marie-Hélène Lafeuille, Aurélie Côté-Sergent, Patrick Lefebvre, Neeta Tandon, Antoine C. El Khoury
Publikováno v:
Drugs - Real World Outcomes, Vol 7, Iss 1, Pp 19-29 (2019)
Abstract Purpose Reducing the dosing frequency of antipsychotics (APs) with long-acting injectables (LAIs) such as once-monthly paliperidone palmitate (PP1M) can improve adherence and clinical outcomes for schizophrenia patients. This US study compar
Externí odkaz:
https://doaj.org/article/20d418f459ae4b1ea1970c660544aeb2